UnitedHealth, private equity firm likely buyers in $1.6B Magellan deal

UnitedHealth Group and private equity firm Carlyle Group are front-runners in a bid for pharmacy benefits and behavioral health provider Magellan Health, an SVB Leerink analyst told Business Insider.

Advertisement

An announcement on the deal may arrive in the next month or, at the latest, by the end of September, SVB Leerink analyst Ana Gupte told Business Insider. While Dealreporter first said in April that Anthem was a top contender in the sale, Ms. Grupte said Anthem’s recent acquisition of behavioral health provider Beacon Health Options likely takes the insurer out of the running.

Ms. Gupte anticipates that Magellan will be acquired for roughly $85 to $90 a share. As of June 10, Magellan had a market value of $1.6 billion, according to the report.

Read more here.

More articles on payers:
Anthem to cover some WellStar services, state order says
Q&A: Allina Health | Aetna CEO on the joint venture’s first year
UPMC backpedals on controversial prepayment policy

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Advertisement

Next Up in Payer

Advertisement

Comments are closed.